Psilocybin Breakthrough: Study Reveals Potential Application For Body Dysmorphic Disorder
Portfolio Pulse from Juan Spínelli
A study from Columbia University suggests psilocybin, found in magic mushrooms, may help treat body dysmorphic disorder (BDD). Supported by COMPASS Pathways, the study showed improved brain connectivity and symptom relief in BDD patients using COMP360, a synthetic psilocybin formulation.
September 26, 2024 | 9:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
COMPASS Pathways supported a study showing psilocybin's potential in treating body dysmorphic disorder (BDD). The study used COMP360, their synthetic psilocybin formulation, and showed promising results in symptom relief.
The study highlights COMPASS Pathways' COMP360 as a potential treatment for BDD, showing significant symptom relief. This could positively impact CMPS stock as it suggests a new application for their product.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90